Warren Tate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 04:37, October 4, 2019 by Notjusttired (talk | contribs) (remove abbreviation)

Warren Tate, MSc (Well) PhD (Otago) CNZM FNZIC FRSNZ MA-PIMBN, is a New Zealand biochemist and Professor of Biochemistry at the University of Otago.[1]

In 2013, Warren Tate and PhD student Angus Mackay received funding from the Lottery Health Research grants to support their search for a diagnostic blood test for ME/CFS.[2]

Research studies and publications[edit | edit source]

  • 2018, A compromised paraventricular nucleus within a dysfunctional hypothalamus: A novel neuroinflammatory paradigm for ME/CFS[3]
  • 2019, Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome[4] - (Full text)
  • 2019, Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[5] - (Full text)
  • 2019, Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[6] - (Full text)

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Professor Warren Tate profile at University of Otago". Cite has empty unknown parameter: |dead-url= (help)
  2. ↑ "Otago Daily Times". Cite has empty unknown parameter: |dead-url= (help)
  3. ↑ Mackay, Angus; Tate, Warren P. (December 2018). "A compromised paraventricular nucleus within a dysfunctional hypothalamus: A novel neuroinflammatory paradigm for ME/CFS". International Journal of Immunopathology and Pharmacology. doi:10.1177/2058738418812342.
  4. ↑ Sweetman, Eiren; Ryan, Margaret; Edgar, Christina; Mackay, Angus; Vallings, Rosamund; Tate, Warren (January 2019). "Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome". International Journal of Immunopathology and Pharmacology. 33. doi:10.1177/2058738418820402.
  5. ↑ Tate, Warren; Ryan, Margaret; Vallings, Rosamund; Helliwell, Amber; Mackay, Angus; Edgar, Christina; Noble, Alex; Sweetman, Eiren (July 2019). "Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Diagnostics. 9 (3): 73. doi:10.3390/diagnostics9030073.
  6. ↑ Sweetman, Eiren; Noble, Alex; Edgar, Christina; Mackay, Angus; Helliwell, Amber; Vallings, Rosamund; Ryan, Margaret; Tate, Warren (July 10, 2019). "Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Diagnostics. 9 (3): 73. doi:10.3390/diagnostics9030073. ISSN 2075-4418.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=Warren_Tate&oldid=72372"